Sharechat Logo

Paymark lifts annual profit by 17 percent on cost control, rising sales

Wednesday 5th September 2012

Text too small?

Paymark, the electronic payments company owned by New Zealand's four biggest banks, lifted full-year profit by 17 percent as revenue rose and it kept costs under control.

Profit rose to $9.6 million in the 12 months ended March 31, from $8.27 million a year earlier, according to its financial statements filed with the Companies Office. Revenue rose 2.4 percent to $44.9 million.

Expenses fell 2.3 percent to $31.4 million even as employee benefits, the biggest cost item, gained 9.2 percent to $13 million. Communication expenses declined about 22 percent to $6.4 million.

Paymark, which is equally owned by ASB Bank, ANZ National Bank, Westpac Banking Corp and Bank of New Zealand, processes 75 percent of New Zealand's electronic transactions via 115,000 terminals through 74,000 merchants.

A Paymark spokesman wasn't immediately available to comment on the results. Last month, the company said transactions through its networks rose 0.8 percent to $3.7 billion in July from a year earlier.

The company declared a dividend of $5 million on June 7, subsequent to the period covered by the accounts.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report